Oxyntomodulin inhibits food intake in the rat

Endocrinology

Volumn 142, Issue 10, 2001, Pages 4244-4250

  Dakin, C L ^a   Gunn, I ^a   Small, C J ^a   Edwards, C M B ^a   Hay, D L ^a   Smith, D M ^a   Ghatei, M A ^a   Bloom, S R ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLICENTIN; GLUCAGON; GLUCAGON LIKE PEPTIDE 1; OXYNTOMODULIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; FEEDING BEHAVIOR; FOOD INTAKE; HORMONAL REGULATION; HORMONE RECEPTOR INTERACTION; HYPOTHALAMUS PERIVENTRICULAR NUCLEUS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0034807498     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.142.10.8430     Document Type: Article

References (45)

1. Preproglucagon gene expression in pancreas and intestine diversifies at the level of post-translational processing
2. Role of prohormone convertases in the tissue-specific processing of proglucagon
3. The glucagon superfamily: Precursor structure and gene organization
4. The entero-insular axis: The new incretin candidate glucagon-like pephde-1(7-36)amide (GLP-1(7-36))amide
5. Glucagon-like peptide-1 (7-36 amide): A potent glucagonostatic and insulinotropic hormone
6. Glucagon-like peptide 1 has a physiological role in the control of postprandial glucose in humans: Studies with the antagonist exendin 9-39
7. Glucagon-like peptide-1 is a physiological incretin in rat
8. A role for glucagon-like peptide-1 in the central regulation of feeding
9. Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats
10. Glucagon-like peptide 1-a new physiologic mediator of satiety?
11. Autoradiographic localization of receptors for glucagon-like peptide-1 (7-36) amide in rat brain
12. Distribution of GLP-1 binding sites in the rat brain: Evidence that exendin-4 is a ligand of brain GLP-1 binding sites
13. PVN infusion of GLP-1-(7-36) amide suppresses feeding but does not induce aversion or alter locomotion in rats
14. The proglucagon-derived peptide, glucagon-like peptide-2, is a neurotransmitter involved in the regulation of food intake
15. Glicentin inhibits gastric acid secretion in the rat
16. Isolation of glucagon-37 (bioactive enteroglucagon/oxyntomodulin) from porcine jejuno-ileum. Isolation of the peptide
17. Bioactive enteroglucagon (oxyntomodulin): Present knowledge on its chemical structure and its biological activities
18. Bioactive "enteroglucagon" (oxyntomodulin): Evidence for a C-terminal extension of the glucagon molecule
19. Oxyntomodulin and its C-terminal octapeptide inhibit liquid meal-stimulated acid secretion
20. Oxyntomodulin from distal gut. Role in regulation of gastric and pancreatic functions
21. H-Lys-Arg-Asn-Lys-Asn-Asn-OH is the minimal active structure of oxyntomodulin
22. Oxyntomodulin (glucagon-37) and its C-terminal octapeptide inhibit gastric acid secretion
23. N-Acetyl oxyntomodulin30-n37: Pharmacokinetics and activity on gastric acid secretion
24. Demonstration of a specific receptor site for glucagon-37 (oxyntomodulin/bioactive enteroglucagon) in rat oxyntic glands
25. Glucagon-like peptide-1-(7-36) amide, oxyntomodulin, and glucagon interact with a common receptor in a somatostatin-secreting cell line
26. 2
27. Oxyntomodulin and glicentin: Brain-gut peptides in the rat
28. Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas
29. Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting β-cells
30. Once daily injection of exendin-4 to diabetic mice achieves long-terra beneficial effects on blood glucose concentrations
31. Glucose-lowering and insulin-sensitizing actions of exendin-4: Studies in obese diabetic (ob/ob, db/db) mice, diabetic fatty Zucker rats, and diabetic rhesus monkeys (Macaca mulatta)
32. Colocalization of glucagon-like peptide-1 (GLP-1) receptors, glucose transporter GLUT-2, and glucokinase mRNAs in rat hypothalamic cells: Evidence for a role of GLP-1 receptor agonists as an inhibitory signal for food and water intake
33. 2
34. Exendin-(9-39) is an inverse agonist of the murine glucagon-like peptide-1 receptor: Implications for basal intracellular cyclic adenosine 3′,5′-monophosphate levels and β-cell glucose competence
35. The effect of the orexins on food intake: Comparison with neuropeptide Y, melanin-concentrating hormone and galanin
36. Hypothalamic localization of the feeding effect of agouti-related peptide and α-melanocyte-stimulating hormone
37. The orexins: Effects on behavior and localization of orexin receptor 2 messenger ribonucleic acid in the rat brainstem
38. Glucagon-like peptide-1 (GLP-1) releases thyrotropin (TSH): Characterization of binding sites for GLP-1 on α-TSH cells
39. Structure-function analysis of stimulation of food intake by neuropeptide Y: Effects of receptor agonists
40. Comparison of the effect of native glucagon-like peptide 1 and dipeptidyl peptidase IV-resistant analogues on insulin release from rat pancreatic islets
41. Biological activity of GLP-1-analogues with N-terminal modifications
42. Oxyntomodulin and its (19-37) and (30-37) fragments inhibit histamine-stimulated gastric acid secretion in the conscious rat
43. Prototypic G protein-coupled receptor for the intestinotrophic factor glucagon-like peptide 2
44. Cloning and functional expression of the human islet GLP-1 receptor: Demonstration that exendin-4 is an agonist and exendin-(9-39) an antagonist of the receptor
45. Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum